Hyperlipoproteinemias

7 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.

Broader: Dyslipidemias, Hyperlipidemias, Lipid Metabolism Disorders, Metabolic Diseases

Narrower: Homozygous Familial Hypercholesterolemia 2, Hyperlipoproteinemia Type I 1, Hyperlipoproteinemia Type II 4, Hyperlipoproteinemia Type V 1

Treatments and conditions

Hyperlipoproteinemias
Treatment and conditionWhere it standsTrials
Autoinjector + EVOLOCUMAB for hyperlipoproteinemiasTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
CTX310 for homozygous familial hypercholesterolemiaPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
CTX310 for hyperlipoproteinemia type vPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Enlicitide Decanoate for hyperlipoproteinemia type iiPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)3
Olezarsen for hyperlipoproteinemia type iPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
SHR-1918 for homozygous familial hypercholesterolemiaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
VERVE-102 for hyperlipoproteinemia type iiPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1

Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.